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ABSTRACT 
Objective 
There is limited data for counseling and management of periviable small for gestational age 
fetuses. We aim to investigate short term outcome in periviable SGA fetuses and relate this to the 
underlying cause. 
Methods 
Retrospective database study conduced in three London tertiary fetal medicine centres between 
2000 and 2015. We included viable singleton pregnancies with abdominal circumference ≤ 3rd 
percentile between 22+0 and 25+6 weeks. Data obtained included biometry and placental 
anomalies, uterine and fetal Doppler and neonatal outcome. We excluded those cases with 
demonstrated structural abnormalities, proven or suspected abnormal karyotype or genetic 
syndromes. Cases were categorised as uteroplacental insufficiency, evidence of placental damage 
with normal uterine artery Doppler, viral infection or unclassifiable. 
Results 
245 cases were included. At diagnosis 201/245 (82%) were categorised as uteroplacental; 13/245 
(5.3%) as suspected placental and 30 could not be assigned to any of these categories. Overall, 
101/245 (41%) survived; the rate of in utero fetal demise was 89/245 (36%), 22/245 (9%) were 
neonatal deaths and 33/245 (14%) of pregnancies were terminated. The diagnosis to delivery 
interval was 8.1 weeks in those that survived, 2.7 weeks in those that died in utero and 3.9 weeks 
in those that died neonatally. 
Conclusions 
Over 90% of periviable SGA cases are associated with uteroplacental insufficiency or intraplacental 
damage. Survival is related to gestation at delivery, with outcomes better than might be assumed 
at diagnosis and some pregnancies reaching term.  
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INTRODUCTION 
Despite recent improvements in perinatal survival after birth at preterm gestation as detailed in 
large prospective studies such as TRUFFLE1, EPICURE2, or GRIT3, management of pregnancies with 
a very small fetus near the limit of viability remains a challenge4. The perinatal and 2-year 
neurodevelopmental outcomes of growth restricted babies identified after 26 weeks have been 
evaluated and well characterised in randomised controlled trials, aiding prognostication and 
counselling1,3,5. However, when the diagnosis occurs before 26 weeks of gestation, there are scant 
data to aid in counseling regarding prognosis; this is particularly important as babies with these 
conditions combine two major risk factors for morbidity and mortality: pathological smallness and 
likely extreme prematurity6,7. This is usually due to medically indicated preterm delivery because 
of fetal deterioration or maternal complications. 
Careful counseling of the parents is required in such cases in order to have realistic expectations of 
what the outcome is likely to be, in order to reach a decision on whether (and, if so, when) 
intervention by delivery is appropriate or desirable3,6 and what level of neonatal intervention is 
likely to be required. Given the very limited data on which these decisions are based currently, we 
aimed to determine the outcome of periviable SGA babies in relation to the likely underlying cause 
and its natural history in fetuses that were structurally and presumed to be 
chromosomally/genetically normal at the time of SGA diagnosis. 
It is important to note that the terms small for gestational age (SGA) and fetal growth restriction 
(FGR) are frequently used in different ways and the definitions are not uniform even in 
international guidelines. We therefore use the term SGA to describe a fetus whose size based on 
ultrasound scan is very small in relation to gestation without any other qualifying characteristics. 
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MATERIALS AND METHODS 
This was a multicentre retrospective database study conducted in the fetal medicine departments 
of three tertiary London perinatal units: Queen Charlotte’s and Chelsea Hospital (QCCH), Guys and 
St Thomas’s Hospital (GSTH) and St George’s Hospital (SGH). All singleton, severely small fetuses, 
defined as abdominal circumference (AC) ≤3rd percentile for gestation (AC calculated according to 
UK recommended standard and Chitty chart8) diagnosed on ultrasound between 22+0 and 25+6 
weeks from 2000 to 2015 were identified from medical databases used for routine clinical care: 
Astraia (Astraia software GmbH, Munich) at QCCH and GSTH and Viewpoint (GE healthcare 
software, Frankfurt) at SGH. For this study research ethics approval was not required as all cases 
were routinely and retrospectively collected and datasets were fully anonymised prior to analysis. 
Once the cases were identified, review of electronic ultrasound records and, where appropriate, 
case notes was undertaken.  
 
The first qualifying ultrasound scan within the set gestation was considered to be the “sentinel 
scan” and its findings were analysed for the study. Fetuses where intrauterine death (IUD) was 
diagnosed at the sentinel scan were not included in this study. The gestational age was based on 
routine first trimester ultrasound dating between 11+0 and 13+6 weeks’ gestation. Fetal biometry 
and Doppler studies were performed by fetal medicine specialists using a variety of ultrasound 
machines over the 15 year period. Maternal demographic data were collected including maternal 
age, parity and diagnosis of pre-eclampsia (PE). Ultrasound parameters were gestational age at 
inclusion, fetal anatomical assessment, fetal biometry (biparietal diameter (BPD), head 
circumference (HC), abdominal circumference (AC), femur length (FL), estimated fetal weight 
(EFW) using the Hadlock 4 parameter model9, HC/AC ratio as well as subjective assessment of 
amniotic fluid volume and placental appearance. Doppler indices included umbilical artery 
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pulsatility index (UA PI) and umbilical artery end diastolic flow (UA EDF) and, where available, 
middle cerebral artery pulsatility index (MCA PI), cerebro-placental ratio (CPR), ductus venosus 
pulsatility index (DV PI) as well as DV a-wave and maternal uterine artery Doppler pulsatility index 
(Ut Art PI). Information regarding invasive testing and congenital infection screening tests was 
collected if available. All data was collected anonymised in all centres from a preformatted Excel 
(Microsoft Corp 2007) spreadsheet. We did not collect information regarding previous medical and 
obstetric history and mode of conception as this data was not routinely reported in the ultrasound 
scan reports. 
 
The fetal outcomes were collected from the hospital clinical databases and neonatal outcomes 
obtained from the regional neonatal database (Badgernet, NHS Patient Data Management 
System). Outcomes for pregnancies that were discharged from the tertiary centres and referred 
back to local hospitals for delivery were collected by direct telephone enquiries to the respective 
units. Postnatal data collected consisted of gestation at delivery, diagnosis-to-delivery interval, 
birthweight and pregnancy outcome in terms of postnatal survival (i.e.livebirth, neonatal death 
(NND), IUD and fetocide / termination of pregnancy (TOP). Neonatal death was defined as a death 
within 28 days after birth. We excluded cases where the postnatal outcome was incomplete or 
missing. Also excluded were cases with ultrasonographically suspected or confirmed (following an 
abnormal invasive test result) underlying genetic/chromosomal abnormalities or stigmata of 
infection. 
 
Each case was selected into a category of suspected underlying cause of small fetal size by the 
study investigators, two of whom in each centre reached consensus if there was uncertainty about 
the categorisation. In order to mirror clinical practice this initial categorisation was exclusively 
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based on the antenatal ultrasound findings documented by the operator at the time of diagnosis 
at sentinel scan. The operator had no access to the outcome of the case at the time of sentinel 
scan. Each case was then reviewed a second time postnatally with the knowledge of genetic and 
infectious screening results - if available - as well as with knowledge of postnatal outcome. In 
some cases the antenatally suspected cause and categorisation differed from the postnatal cause. 
The cases were classified into one of four mutually exclusive categories depending on suspected 
underlying cause: 
- Uteroplacental: uterine artery PI above 95th percentile for gestation and/or bilateral notches 
and/or reduced amniotic fluid. 
- Placental: ultrasound evidence of placental abnormality (thickened placenta, extensive lakes or 
jelly like appearance) with the presence of normal uterine artery Doppler assessment (PI below 
the 95th centile and absence of bilateral notches). 
- Congenital infection. 
- Unclassified: in cases that did not fulfill the criteria for the defined categories above, and where 
no antenatal cause of fetal growth restriction was initially identified. 
Statistical data analysis was performed with SPSS Statistical software version 20. Outcome 
frequencies were calculated and compared across the groups with the Kruskal-Wallis test. We 
considered p<0.05 as significant. 
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RESULTS 
471 pregnancies were identified: 239 from QCCH, 51 from GSTH and 181 from SGH. 245/471 
singleton pregnancies fulfilled the inclusion criteria (Figure 1). The median gestational age at 
sentinel ultrasound was 23+4 (22+0 – 25+6) weeks gestation. Mothers had a median age of 32 (17–
46) years, with 54% nulliparous women and 33% of mothers with PE in the included pregnancy. 
75/245 patients underwent viral infection testing. Of the 245 cases 55 underwent invasive testing 
which confirmed normal results. In 190/245 cases invasive testing was declined by the parents, not 
offered nor undertaken by the clinicians and of these 3 had low risk results from non-invasive cell 
free fetal DNA testing.  
There were no significant differences between the baseline demographic data (maternal age, 
gestation at diagnosis, AC, EFW, placental appearance) for the cases analysed (245 cases of 
structurally normal fetuses with known outcome) and those cases of structurally normal fetuses 
excluded because of missing outcome data (79 cases). However, PE was more common in those 
analysed compared to those with no outcome (33% versus 16% p=0.04). Of 245 pregnancies, 33 
underwent termination of pregnancy by fetocide or medical TOP; 89 died in utero (IUD) and 123 
were liveborn. Of these 101/123 (82%) survived the neonatal period. Figure 2 shows the fetal 
outcome by categorisation at sentinel scan. Of the 123 babies born alive those born below 28 
weeks the survival rate was 13%. Survival increased progressively to 59% between 28 and 32 
weeks, to 80% between 32 and 36 weeks and to 94% above 36 weeks (Table 1 and figure 3). 
Antenatal categorisation at sentinel scan according to the suspected underlying cause identified 
201 cases of uteroplacental cause; 13 cases of placental cause and 1 case of suspected viral cause. 
This case had no ultrasound stigmata typical of in utero infection but there was a clinical history of 
possible maternal infection which lead to the categorisation at sentinel scan. The remaining 
30/245 cases were unclassified. Antenatal ultrasound findings of the included cohort are shown in 
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table 2. Cases that changed their antenatal category postnatally are shown in table 3. There were 
10 cases that were categorised as unclassified antenatally and changed category after postnatal 
review. Furthermore, there was one case that was antenatally categorised as uteroplacental – and 
changed to the category unclassified postnatally. 
The relationship between antenatal and delivery characteristics in relation to postnatal outcome 
are shown in table 4: those babies that survived had higher birthweights and a longer diagnosis-
delivery interval then those that were IUD, NND and underwent TOP. There were significant 
differences in the median birthweight, diagnosis-to-delivery interval and Table 5 shows the 
outcomes by categorisation of SGA: the incidence of PE was highest in SGA associated with 
uteroplacental insufficiency (34%) and gestation longest in those cases that were unclassified (34.9 
weeks). APGAR scores between those fetuses that survived and those that suffered a neonatal 
death (NND). 
There were 143/245 (58.5%) vaginal deliveries and among these two were instrumental deliveries. 
In 2/245 (1%) no information on mode of delivery was available. Of the 99/245 (40.5%) Caesarean 
sections, 64/99 (65%) were planned Caesarean sections and 35 (35%) were emergency procedures. 
Among the 101/245 fetuses (41%) that survived, 82/101 (81%) were delivered by Caesarean section 
and 18/101 (18%) were delivered vaginally. In one survivor, the mode of delivery was unknown. 
There were 22/245 neonatal deaths. 5/22 (23%) were delivered vaginally and 16/22 (72.5%) were 
delivered by Caesarean section. In one neonatal death the mode of delivery was unknown.  
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DISCUSSION 
In this cohort of very small fetuses identified at periviable gestation, survival overall was 41% and, 
ranging from 13% if delivery was <28 weeks up to >90% if babies were delivered at beyond 36 
weeks. The majority of these cases had uteroplacental insufficiency. Noteworthy is that where 
severely small fetal biometry was identified at periviable gestation, 15% of pregnancies were 
delivered after 36 weeks with good outcome. Outcome is worse in cases of uteroplacental 
insufficiency than in those with a primary placental cause; nearly one third of women with 
uteroplacental SGA develop PET, twice as many as those with placental cause or unclassified SGA. 
The pregnancies progressing longest from diagnosis and with the best prognosis are those where a 
cause for SGA cannot be classified at the sentinel scan. These data are of clinical relevance as 
counseling for parents can be based on the cause identified at sentinel scan. 
The small fetus remains a challenge to define and diagnose and there may be overlap between 
SGA and true FGR, especially if diagnosed at periviable gestation10. Doppler and placental 
assessment carries both diagnostic and prognostic value11 allowing most fetuses to be classified at 
presentation. The great majority of structurally normal fetuses found to measure very small at 
periviable gestation were classified into the utero-placental category, a smaller number of 
pregnancies being affected by primary placental abnormality and only one by a confirmed viral 
infection. Twelve percent had no obvious antenatal pathological cause found at sentinel scan and 
the majority of these fetuses (53%) survived, with the others dying as a result of TOP, IUD or NND. 
Although it was not possible at time of diagnosis to differentiate between FGR and SGA in all 
cases, the unclassified cases were likely to represent SGA as they showed no stigmata of 
uteroplacental or placental problems and some reached a gestation close to term. 
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In very small fetuses at periviable gestation the differentiation between SGA and FGR is important 
as it guides prognosis. By measuring and describing the relevant ultrasound findings we are able to 
classify most fetuses at presentation at periviable gestation, however it remains difficult to predict 
with any level of precision which fetuses will die in utero or which will progress for many weeks or 
even to term before requiring delivery. Though termination of pregnancy is often discussed at 
initial presentation, given the range in gestation at eventual delivery may be far greater than 
expected, there is in fact little to be lost by conservative management. 
When the small fetus has reached a potentially viable weight and gestation the challenge is to 
optimise timing of delivery: balancing the risk between intrauterine demise or hypoxic damage 
while gaining maturity versus delivering a live baby at risk of neonatal complications from 
prematurity and underlying growth restriction2. Post delivery neonatal morbidity in fetuses with 
severe FGR includes respiratory and gastro-intestinal complications and neuro-developmental 
delay. Not surprisingly, the prognosis of a structurally normal, growth restricted fetus is 
determined by gestation at delivery, birthweight and cardiovascular status 12,13,14,15. 
The strength of this study is that we collected data from three large specialist perinatal centres, 
making it the largest dataset on periviable fetal growth restriction reported. The three centres had 
similar reporting and management strategies, though they cannot be considered to be entirely 
uniform as no guidelines existed (or indeed even exist now) in relation to periviable SGA. This 
latter point emphasizes the importance of our data and findings. The cases are well characterised 
and almost all the antenatal and outcome data were held in computerised databases. The data are 
likely to be valid in other populations due to the diverse mix of ethnicities and socioeconomic 
backgrounds. We acknowledge the limitations of these data which was retrospectively collected 
and necessarily only cases where the outcome was known could be included. 
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Further, it was not possible to investigate the effect of steroid administration, magnesium 
sulphate use and mode of delivery as this information was not held in the fetal medicine 
databases and not uniformly documented in delivery databases. This does not affect the validity of 
the findings, but it does mean that the perinatal/obstetric factors that may contribute to better or 
worse outcome could not be sub-analyzed. There were a number of cases lost to follow up but this 
was not a systematic failing as the demographic details did not differ between the cases where 
outcome was known and not known. No longer term infant or child follow up data are included: 
this is desirable for a future prospective study. 
 
CONCLUSION 
This study contributes to the knowledge on short term outcome of severely small fetuses 
diagnosed at the limits of viability. The findings suggest that many pregnancies progress weeks 
beyond what might be envisaged and several unexpectedly reached close to term. We urge caution 
in offering termination of pregnancy as it is frequently impossible to prognosticate and in 
particular to predict how long the pregnancy will progress. 
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Table 1:  
Fetal outcome by gestational age 
 
Delivery at 
<28+0 
Weeks 
28+1 to 32+0
weeks 
32+1 to 36+0
weeks 
>36 +0 
weeks 
 
Gestation 
at 
delivery 
not 
known 
 
 
Survived 
N 101 
 
17 
(13%) 
 
31 
(59%) 
 
19 
(80%) 
 
34 
(94%) 
0 
 
Neonatal 
death 
N 22 
 
12 
(9%) 
 
6 
(11%) 
 
1 
(4%) 
 
2 
(6%) 
 
1 
 
 
IUD 
N 89 
 
68 
(53%) 
 
14 
(26%) 
 
4 
(16%) 
0 
 
3 
 
 
Fetocide/TOP 
N 33 
 
31 
(25%) 
 
2 
(4%) 
0 0 0 
 
Total 
N 245 
 
128 
 
53 24 36 4 
IUD=Intra uterine death 
TOP=termination of pregnancy 
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Table 2:  
Antenatal ultrasound features at sentinel scan (n=245) 
 
  N % 
EFW (g) 
n=245 
353 (166 to 677)* - - 
HC/AC ratio 
n=245 
1.26 (0.98 to 1.55)* - - 
Amniotic fluid subjective 
assessment 
n=234 
Anhydramnios 
 
Oligohydramnios /  
Reduced 
 
        Normal 
14 6% 
91 39% 
129 55% 
Placental appearance 
n=234 
Normal 
Abnormal 
175 75% 
59 25% 
Umbilical PI 
n=185 
1.66 (0.63 to 6.94)* - - 
Umbilical artery EDF 
n=134 
Positive 
Absent 
Reversed 
57 43% 
54 40% 
23 17% 
MCA PI 
n=159 
1.40 (0.80 to 4.49)* - - 
CPR 
n=135 
0.75 (0.22 to 4.05)* - - 
DV a-wave 
n=112 
Positive 
Absent 
Reversed 
96 86% 
11 10% 
5 4% 
 
Antenatal ultrasound features at sentinel scan *median (range) 
 
 
CPR=cerebro-placental ratio 
DV a-wave= Ductus venosus a-wave 
EFW= Estimated fetal weight 
HC/AC ratio= head circumference / abdominal circumference ratio 
MCA PI= Middle cerebral artery PI 
Umbilical artery EDF= Umbilical artery end diastolic flow 
Umbilical PI=Umbilical pulsitility index 
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Table 3:  
Cases that changed category between antenataland postnatal assessment 
Antenatal 
Category at sentinel 
scan 
Postnatal  
Category 
Outcome of case 
Uteroplacental Unclassified  2920g birth weight, IOL; SVD at 39/40, survived 
Unclassified Uteroplacental 270g birth weight, IUD, at 28/40 
Unclassified Placental 385g birth weight, IUD at 26/40,   
Unclassified Uteroplacental 635g birth weight, 27/40, CS, NND 
Unclassified Uteroplacental 250g birth weight, IUD at 22/40 
Unclassified Placental 2550g birth weight, CS at 38/40, survived 
Unclassified Uteroplacental 900g birth weight , IUD at 32 weeks 
Unclassified Placental 440g birth weight, IUD at 24 weeks 
Unclassified Uteroplacental 330g birth weight, TOP at 25/40 
Unclassified Uteroplacental 2620g birth weight, CS at 39/40, survived 
Unclassified Uteroplacental 512g birth weight, CS at 30/40, NND 
 
CS= caesarean section 
IUD= intrauterine death 
NND= neonatal death 
SVD=spontaneous vaginal delivery 
ToP= termination of pregnancy 
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Table 4:  
Antenatal ultrasound variables at sentinel scan and postnatal outcome 
 
 Survived 
N 101 
NND 
N 22 
IUD 
N 89 
Fetocide/TOP 
N 33 
p* 
Gestational age 
at diagnosis 
(weeks)# 
24 
(22 to 25.9) 
23.63 
(22.0 to 25.6) 
23.3 (22.0 to 
25.7) 
23.4 
(22.0 to 25.6) 
n.s. 
EFW at diagnosis 
(g)# 
400 
(256 to 677) 
340 
(246 to 586) 
333 
(166 to 538) 
315 
(213 to 456) 
0.000 
HC/AC ratio at 
diagnosis# 
1,24 
(1.13 to 1.39) 
1.29 
(1.17 to 1.40) 
1.27 
(0.98 to 1.55) 
1.28 
(1.18 to 1.45) 
0.013 
UtA PI abnormal 
or bilat notches 
(uteroplacental 
cause) 
77% (78/101) 86% (19/22) 87% (77/89) 82% (27/33) n.s. 
UA ARED 29% (13/45) 47% (7/15) 72% (34/47) 85% (23/27) n.s. 
DV a-wave absent 
or reversed 
3% (1/33) 0% (0/14) 22.5% (9/40) 24% (6/25) n.s. 
Birthweight (gr)# 1020 
(435 to 3420) 
560 
(313 to 2550) 
422 
(155 to 2570) 
345 
(220 to 512) 
0.000 
Diagnosis to 
delivery interval 
(weeks)# 
8.1 
(0.3 to 18.1) 
4.5 
(0.1 to 15.4) 
2.8 
(0.1 to 10.1) 
0.9 
(0.1 to 5.4) 
0.000 
 
*p value was calculated comparing the median value by Kruskal-Wallis test #Median 
(range) 
 
 
DV a-wave= Ductus venosus a-wave 
EFW= Estimated fetal weight 
g=grams 
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HC/AC ratio= head circumference / abdominal circumference ratio 
IUD= intrauterine death 
NND= neonatal death 
ToP= termination of pregnancy 
UA ARED= Umbilical artery absent or reversed end diastolic flow 
UtA PI=Uterine artery pulsatility index 
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Table 5:  
Outcome based on categorisation of small-for-gestational-age 
 
 Survived NND IUD 
Fetocide
or 
TOP 
Total*
Gestation at 
delivery 
Diagnosis to 
delivery 
interval 
 
Incidence 
of PE 
Utero-
placental 
39% 
78/201 
10% 
19/201 
38% 
77/201
13% 
27/201 
201 
(82%) 
27.5 (22.3-40.3) 
(N 198/201) 
3.7 (0-16) 
(N 198/201) 
34% 
(49/145) 
Placental 
54% 
7/13 
0% 
0/13 
15% 
2/13 
31% 
4/13 
13 
(5.3%)
27.0 (22.6-38.3) 
(N 12/13) 
3.6 (0-15.9) 
(N 12/13) 
17% 
(2/12) 
Viral 
0% 
0/1 
0% 
0/1 
100% 
1/1 
0% 
0/1 
1 
(0.5%)
n.a. n.a. 
0% 
(0/1) 
Unclassified 
53% 
16/30 
10% 
3/30 
30% 
9/30 
7% 
2/30 
30 
(12.2%)
34.89 (22.3-41.3) 
(N 30/30) 
11.9 (0-18.1) 
(N 30/30) 
11% 
2/18 
Total 101 22 89 33 245 
27.7 (22.3-41.3) 
(N 241/245) 
3.9 (0-18.1) 
30% 
53/175 
 
Antenatal outcome by categorisation* 
NND= neonatal death 
IUD= intrauterine death 
ToP= termination of pregnancy 
PE= preeclampsia 
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Figure 1:  
Flow chart (according to STROBE guidelines) for inclusion of cases 
 
 
  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Total included cases n= 471 
 
Viable singleton pregnancies at 22+0 
rd
Excluded because of 
abnormality at sentinel 
scan: n=147 
 
1) Genetic / chromosomal 
anomaly n=47
No abnormality but excluded 
as no outcome available 
postnatally: 
Included in analysis: 
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Figure 2:  
Fetal outcome by antenatal categorisation 
 
 
 
Fetal outcome by antenatal categorisation at sentinel scan (uteroplacental n= 201; 
placental n= 13; unclassified n= 30). (viral category not shown as n=1) 
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Figure 3:  
Fetal outcome by gestational age  
 
 
 
Fetal outcome by gestational age in weeks at delivery (<28 weeks n= 128; 28+1 – 32 
weeks n= 53; 32+1 – 36 weeks n= 24; >36 weeks n= 36). (unknown gestation n= 4; 
IUD n= 3; NND n= 1) 
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